All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia (Q31922432)

5 July 2017

1 reference

title

All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia (English)

1 reference

acute promyelocytic leukemia

5 July 2017

0 references

1 reference

1 reference

1 reference

1

Fenaux P

1 reference

5 July 2017

Chomienne C

2

1 reference

PubMed ID

11172536

5 July 2017

Degos L

series ordinal

3

1 reference

5 July 2017

1 January 2001

1 reference

5 July 2017

Seminars in Hematology

1 reference

5 July 2017

38

1 reference

5 July 2017

13-25

1 reference

5 July 2017

1

1 reference

Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.

5 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Hypercalcaemia due to all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Acute promyelocytic leukemia relapse in the central nervous system during hematologic and molecular remission

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

A variant form of hypergranular promyelocytic leukemia (M3)

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Preliminary experience in external quality control of RT-PCR PML-RAR alpha detection in promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Extramedullary disease in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. European APL Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Treatment of Acute Promyelocytic Leukemia: A Report of 70 Cases

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Role of maintenance chemotherapy in acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia--the occurrence of retinoic acid syndrome is a risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Fournier's gangrene during induction treatment of acute promyelocytic leukemia, a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Extramedullary involvement in patients with acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Tretinoin toxicity in children with acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Myositis with tretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

Multiple thrombosis in acute promyelocytic leukaemia after tretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990002-2

7 January 2021

10.1016/S0037-1963(01)90002-2

Identifiers

DOI

1 reference

5 July 2017

1 reference

PubMed ID

11172536